Correlation of ACE insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients.
Dewa A S HandaniAdam HermawanZullies IkawatiPublished in: Pharmacogenomics (2024)
Background: Hypertension is a prevalent health concern in Indonesia, with a high percentage of patients unresponsive to ACE inhibitor treatment. Methods: This multicenter case-control study investigated the correlation between ACE I/D and captopril effectiveness in Indonesian hypertensive patients. Hypertensive patients were divided into control (n = 69) and case (n = 73) groups. ACE I/D was identified using PCR and electrophoresis. Results: No significant differences in genotype frequencies or allele distribution were observed. The difference of blood pressure reduction among the three genotypes also lacked statistical significance. Conclusion: ACE I/D is not significantly associated with blood pressure reduction following captopril therapy in Indonesian hypertensive patients. These results underscore the limited predictive utility of ACE I/D in managing hypertension with captopril.
Keyphrases
- hypertensive patients
- blood pressure
- angiotensin converting enzyme
- angiotensin ii
- heart rate
- randomized controlled trial
- end stage renal disease
- systematic review
- healthcare
- public health
- mental health
- newly diagnosed
- chronic kidney disease
- prognostic factors
- stem cells
- peritoneal dialysis
- adipose tissue
- type diabetes
- bone marrow
- risk assessment
- cross sectional
- metabolic syndrome
- patient reported
- high resolution
- insulin resistance
- weight loss
- mass spectrometry
- atomic force microscopy
- single molecule
- climate change
- smoking cessation